ANTHEM BIOSCIENCES LTD vs SUN PHARMACEUTICAL IND L
A side-by-side comparison of ANTHEM BIOSCIENCES LTD (ANTHEM) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, ANTHEM BIOSCIENCES LTD leads ANTHEM vs SUNPHARMA on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation13
- Profitability40
- Growth20
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
SUNPHARMA takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
ANTHEM takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
ANTHEM takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has reduced debt.", "Company is almost debt free.", "Company's working capital requirements have reduced from 118 days to 92.3 days"]
- − ["Stock is trading at 16.6 times its book value", "Promoter holding has decreased over last quarter: -3.25%"]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.